COVID-19 Leads to Decrease in Smoking Cessation Attempts: Study

Aug.09.2022
COVID-19 Leads to Decrease in Smoking Cessation Attempts: Study
A recent study by JAMA Network Open found that smoking cessation attempts decreased by 2.9% in 2020, attributed to the spread of COVID-19 in the US.

According to a recent study by JAMA Network Open, the number of individuals attempting to quit smoking decreased by 2.9% in 2020 compared to 2019. The study attributed this decline to the spread of COVID-19 in the United States. This finding was part of a 10-year study tracking nearly 800,000 people who reported smoking daily or for most of the week. The largest decrease in quit attempts occurred in April, May, and June of 2020, with a 3.4% decline compared to the same period in 2019. However, the number of successful quitters has significantly increased since 2011.


The study also examined the sales of nicotine replacement therapies such as gum, lozenges, and patches. These products saw a 13% decrease in sales in 2020 compared to expected sales, and the decline continued into early 2021. However, sales started to recover in April, May, and June of 2021.


The findings of this study align with those of a smoking cessation hotline. According to data from the North American Quitline Consortium, demand for smoking cessation services declined from February to June of 2020 and continued on a downward trend in 2021 until March and April, when demand returned to pre-pandemic levels.


A recent study contradicts a commentary in BMJ Open earlier this year, suggesting that smoking during the COVID-19 pandemic may actually increase the likelihood of quitting. The study examined smokers, e-cigarette users, and those who used both nicotine products. Those who only smoked felt a higher risk of getting infected with COVID-19 and therefore were more motivated to quit. The study suggests that if smokers were made aware of the increased susceptibility to disease caused by smoking, they would be more likely to quit, particularly if they were older.


On the other hand, research has found an increase in the use of electronic cigarettes during the COVID-19 pandemic. These users perceive electronic cigarettes as less harmful and potentially a substitute for traditional cigarettes, leading to a lower likelihood of quitting smoking during the pandemic. The study also found that those who use both cigarettes and electronic cigarettes tend to purchase more cigarettes, further increasing their usage.


Statement


This article is compiled from third-party information and is for industry exchange and learning purposes only.


This article does not represent the views of 2FIRSTS and they cannot confirm the truthfulness or accuracy of the content. The translation of this article is only intended for industry communication and research purposes.


Due to limitations in the level of translation, the translated article may not fully convey the intended meaning of the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government in regards to any domestic, Hong Kong/Macau/Taiwan-related, or foreign statements and positions.


The compiled information is copyrighted to the original media and author. If there is infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

KT&G Plans $200 Million Acquisition of Nordic Pouch Company
KT&G Plans $200 Million Acquisition of Nordic Pouch Company
KT&G is considering acquiring a Nordic nicotine pouch maker for about KRW 300 billion (USD 200 million), its largest overseas deal since 2011, according to sources. The move aims to boost its oral nicotine portfolio as cigarette sales decline and regulations tighten. KT&G declined to comment, saying no decision has been finalized.
Jun.04 by 2FIRSTS.ai
New Zealand Official Says Vaping Rules Outperform Australia’s, Backs “Licensing Plus Regulation” Approach to Tobacco Control
New Zealand Official Says Vaping Rules Outperform Australia’s, Backs “Licensing Plus Regulation” Approach to Tobacco Control
New Zealand’s Customs Minister and Associate Health Minister Casey Costello stated that the country’s sharp decline in smoking rates is largely due to its “licensing plus regulation” approach to vaping, rather than outright bans. She noted that this model has proven more effective than Australia’s blanket prohibition policy.
Jun.10 by 2FIRSTS.ai
Singapore Installs E-cigarette Disposal Bins to Prevent Etomidate Abuse
Singapore Installs E-cigarette Disposal Bins to Prevent Etomidate Abuse
Singapore launched the “Bin the Vape” program with 24 secure bins to prevent misuse of e-cigarettes possibly containing etomidate. With the drug soon classified as Class C, stricter penalties include rehab for users, jail for repeat offenders, and up to 20 years’ imprisonment for sellers.
Jul.29 by 2FIRSTS.ai
U.S. Tobacco Firm Cabbacis Secures Pod Patent for Low-Nicotine and Industrial Hemp Blends
U.S. Tobacco Firm Cabbacis Secures Pod Patent for Low-Nicotine and Industrial Hemp Blends
U.S. tobacco maker Cabbacis has secured a USPTO patent (No. 12,349,724) for oral vaporizer pods, effective until July 2038. With existing patents, its iBlend™ harm-reduction products—featuring low-nicotine and hemp blends—are now protected in over 30 countries and key global tobacco markets.
Jul.18 by 2FIRSTS.ai
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
The U.S. Food and Drug Administration has officially launched Elsa, a generative AI tool designed to speed up clinical reviews, internal writing, and data processing tasks. After successful pilots across multiple departments, Elsa is now being rolled out agency-wide.
Jun.04 by 2FIRSTS.ai
PMI Shares KPMG Report on Social Media: EU Illicit Cigarette Consumption Rises 20% as Prohibitive Policies and Excessive Taxation Fuel Black Market
PMI Shares KPMG Report on Social Media: EU Illicit Cigarette Consumption Rises 20% as Prohibitive Policies and Excessive Taxation Fuel Black Market
Philip Morris International (PMI) shared a KPMG report on social media revealing a 20% increase in illicit cigarette consumption across the EU. The report warns that excessive regulation is fueling black markets and calls for a comprehensive response—including science-based policies and stronger enforcement—to address this global threat to public health and safety.
Jun.26 by 2FIRSTS.ai